1-(2-Bromo-6-fluoro-phenyl)-2,2,2-trifluoro-ethanone, 5g

5-BROMO-1-METHYL-2-PHENYL-1H-IMIDAZOLE, 95%, 250mg

3-BOC-9-HYDROXY-3-AZASPIRO[5.5]UNDECANE, 97.0%, 250mg

Ethyl 1-methylcyclobutanecarboxylate, 95%, 5g

(4S,5S)-4,5-Diphenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole, 98%, 5g

[2-(1H-indol-3-yl)ethyl][(thiophen-2-yl)methyl]amine hydrochloride, 95.0%, 2g

(5-Bromopentyl)benzene>98.0%(GC)5g

2-Iododibenzofuran>98.0%(GC)1g

5-(Trifluoromethyl)isophthalic acid, 97%, 250mg

3,3-Bis(bromomethyl)-1-tosylazetidine, 95.0%, 1g

(4S,5R)-2-(1,8-Naphthyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 1g

9-([1,1':3',1''-Terphenyl]-4-yl)-9'-phenyl-9H,9'H-3,3'-bicarbazole, 98%, 250mg

p-Xylene, min. 99%, for synthesis, 100 ml, glass packaging